Realbotix: Expressive Humanoids, Unproven Autonomy

Realbotix sells the most lifelike faces in the humanoid business and has yet to show one of them doing a job without a human behind the curtain.

How to Read This Report

This report is built on a deliberately narrow evidence base. The research dossier behind it contains five commerce sources, five news sources, six community sources, and no official product documentation, no peer-reviewed research, and no video corpus. That asymmetry shapes everything that follows. Where a section would normally rest on primary documentation, this report says so plainly rather than filling the gap with inference dressed as fact.

Every substantive statement in this report carries one of four labels. The label is not decoration; it tells you how much weight the statement can bear.

Two rules govern the whole document. First, a choreographed demonstration video is not proof of autonomous work. Second, a partnership announcement is not proof of a paid customer. Realbotix's public record leans heavily on both categories of evidence, and the report treats them accordingly.

A note on the acquisition. The dossier records that Onconetix was reported to have acquired Realbotix on 12 February 2026, with bridge financing preceding the deal ⁹⁸³. The confidence attached to this is moderate (0.7), and the sources are consistent with a pending or completed transaction rather than a fully settled one. Readers should treat the corporate structure as a live variable, not a fixed backdrop.

---

01Executive Overview

Realbotix is a Canadian-listed manufacturer of hyperrealistic humanoid robots, trading on the TSXV under XBOT, the Frankfurt exchange under 76M0, and the OTC under XBOTF ⁶³. The company builds three tiers of product: a robotic bust at roughly $20,000, a modular upper-body humanoid at roughly $95,000, and a full-body robot at $125,000 and above ¹⁴. It employs around 21 people and operates in a field that one commercial database counts at 185 active competitors ⁹. In February 2026 it was reported to have been acquired by Onconetix, following bridge financing from the same party ⁹⁸.

The pitch is narrow and coherent. Realbotix does not claim to sell a general-purpose worker. Its robots are expressive social and customer-facing characters, designed to look and behave like people, with facial articulation, conversational interfaces, and API hooks into third-party AI platforms ¹⁴. The company has announced pilots in a European telecom setting, a UK elderly social-isolation programme with a partner called Bloom, and a US school district deploying a humanoid robot and AI teaching assistant ⁶⁷. These are announced deployments. None has been independently verified as producing a measured outcome.

The central finding of this report is a gap between the sophistication of the hardware and the thinness of the evidence for what it does. Realbotix's faces are genuinely advanced; the dossier contains no competing product at the same price point with comparable facial articulation. But no source in the dossier, vendor or independent, demonstrates a Realbotix robot autonomously performing a task. The autonomy verdict is unknown (confidence 0.4): the evidence neither confirms autonomous operation nor explicitly documents teleoperation. What independent evidence exists points the other way. A first-hand reviewer who tested the $125,000 robots described the experience as unsettling and found the machines lacking emotional awareness ⁵. A community post claiming the robot can understand human emotions carries low confidence and is contradicted by the more credible first-hand account ¹²⁵.

Three judgements follow from this. First, Realbotix is best understood as a character company with a robotics substrate, not a robotics company with a character feature. Its value proposition lives in the face, the skin, the voice, and the scripted interaction, not in manipulation, navigation, or task completion. Second, the commercial model is exposed to a specific risk: if the product's appeal is emotional and the independent evidence says the emotional experience disappoints, the premium pricing rests on novelty rather than utility. Third, the acquisition by Onconetix introduces a strategic question the public record does not answer. Onconetix is a diagnostics and health-sciences company, not a robotics firm ⁹. Whether Realbotix becomes a care-sector channel for a healthcare parent or is absorbed and wound down is genuinely open.

For readers tracking the humanoid sector, Realbotix is a useful counterexample to the general-purpose narrative. It shows what happens when a company optimises for presence rather than capability. That is a legitimate strategy with real markets in hospitality, retail, elder care, and education. It is also a strategy whose evidence base, on the public record, remains almost entirely the company's own.

Latest news

• NY School District Shelves Plan to Spend $58K on Robot Teaching Assistant

  PCMag.com·2026-08-01GENERAL
• High school axes plans to deploy AI-powered robot called Sally in classrooms after discovering her disturbing ties to sex dolls

  Dailymail.com·2026-07-30GENERAL
• Aborted plan for life-like robot in NY classroom alarms state teachers union

  Gothamist·2026-07-27GENERAL
• A New York High School Is Getting an AI-Powered Robot Assistant. Parents and Teachers Have Concerns

  CNET·2026-07-24GENERAL
• Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation

  GlobeNewswire·2026-07-07GENERAL
• Realbotix Partners with Bloom to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation

  Financial Post·2026-07-07GENERAL
• Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District

  GlobeNewswire·2026-06-24GENERAL

---

02The Realbotix Story

Realbotix's public identity is built on a single proposition: that a robot's face is the hard problem, and that the company has solved it. The dossier supports the second half of that claim more than the first. Multiple independent sources describe Realbotix consistently as a developer and manufacturer of customizable, full-bodied, human-like robots with integrated AI and software platforms ³⁹. The consistency across a financial data provider and a private-market database is meaningful; it means the company's self-description has survived contact with at least two independent cataloguing processes.

The corporate history available in the dossier is thin. There is no founding narrative, no funding history beyond the Onconetix bridge, and no account of the company's earlier iterations. What can be established is the present shape: a small public company, roughly 21 employees as of August 2026, listed on three exchanges, with a product line already priced and shipping ⁶⁹. The employee count matters. Twenty-one people cannot simultaneously sustain advanced mechatronics, custom silicone skin fabrication, AI software integration, and a global sales motion. Something in that list is being outsourced, deprioritised, or overstated, and the dossier does not say which.

The most consequential recent event is the reported acquisition by Onconetix on 12 February 2026, preceded by bridge financing from the acquirer ⁹⁸³. The confidence here is 0.7, which reflects that the sources are consistent with a pending or completed deal rather than a fully documented one. EDITORIAL INFERENCE: the bridge financing structure suggests a company that needed capital to reach a transaction, which in turn suggests the standalone commercial trajectory was not self-sustaining at the time. That is an inference, not a disclosed fact, and it should be held loosely. What is not inference is the strategic mismatch: Onconetix operates in diagnostics and health sciences ⁹. A healthcare parent acquiring a companion-robot manufacturer implies a thesis about care settings, patient interaction, or clinical presence. The dossier contains no statement from either company explaining that thesis.

The public communication style is worth noting because it shapes the evidence base. Realbotix's news page and press releases announce deployments and partnerships ⁶⁷⁸. They do not, in the material available, publish performance data, customer retention figures, or third-party evaluations. This is normal for a small public company and it is also the reason this report's confidence score sits at 0.55. The company is legible as an entity and opaque as a business.

---

03Product Portfolio: What Realbotix Actually Sells

Realbotix sells three tiers of robot, distinguished primarily by how much of the human body is present and how many degrees of freedom that body carries. The pricing is unusually transparent for the sector and is corroborated across the vendor site and two independent sources ¹⁴.

VERIFIED FACT: the three price tiers are consistent across the vendor site and two independent commerce and news sources, giving high confidence (0.95) ¹⁴. VERIFIED FACT: the hardware specifications vary by model as listed, with 17 DOF for the bust, 39 DOF for the M Series, and 44 DOF for the full-body unit, and a motorised wheel base with a built-in battery rated at four to eight hours ¹. No independent teardown contradicts these figures, but none confirms them either; the confidence of 0.8 reflects vendor-only sourcing for the specifications themselves.

The wheeled base is the single most revealing design decision in the portfolio. A $125,000 humanoid that rolls rather than walks is not attempting to compete with legged platforms on mobility. It is optimising for stability, battery life, safety in public spaces, and cost. EDITORIAL INFERENCE: this is a deliberate positioning choice that trades the appearance of general capability for reliability in fixed or semi-fixed environments. It is defensible. It also means the product cannot follow a person through a home, navigate stairs, or operate in unstructured terrain, which removes a large share of the use cases that general-purpose humanoid vendors are chasing.

What the robots are for, according to the vendor and one independent commerce source, is expressive social and customer-facing interaction: facial expressions, conversational AI, and API integration with external language models ¹⁴. The same independent source states explicitly that the product is not a household worker ⁴. That is a useful clarity. Realbotix is not overclaiming general capability in its product literature, at least not in the material captured here.

The customisation layer is central to the business model and under-documented in the dossier. Realbotix's proposition is that buyers can specify appearance, personality, and behaviour ¹³. Custom silicone faces and bespoke characters imply per-unit engineering labour, long lead times, and margins that depend on how much of the work is repeatable. UNKNOWN: the dossier contains no information on lead times, customisation costs, production capacity, or whether the robots are built to order or built to stock. For a company at this price point, those variables determine whether the business scales or remains a bespoke workshop with a public listing.

Products & versions

Realbotix Robotic Bust

Entry-tier hyperrealistic robotic bust with 17 motors/17 DOF, priced around $20K, designed for expressive social interaction.

Realbotix M Series (Upper-Body Modular Humanoid)

Modular upper-body humanoid with 39 DOF, priced around $95K, built for customizable customer-facing and companion roles.

Realbotix Full-Body Humanoid

Full-body humanoid robot with 44 DOF and a motorized wheel base with 4-8 hour battery life, priced from $125K+.

---

04Technology Stack: Strengths and the Work That Remains

The technology stack divides into three layers: the mechatronic face, the body and mobility platform, and the AI and software integration. The dossier supports strong claims in the first layer, moderate claims in the second, and weak claims in the third.

The face. This is Realbotix's genuine differentiator. A 17-DOF head with motorised articulation at the bust tier, scaling to 44 DOF across the full body, is a serious piece of mechatronic engineering ¹. The independent reviewer who tested the $125,000 robots found them unsettling, which is itself evidence that the facial realism is effective ⁵. Uncanny-valley responses do not occur in response to crude animatronics; they occur when the simulation is close enough to trigger social cognition and then violates it. EDITORIAL INFERENCE: the reviewer's discomfort is a backhanded confirmation of the hardware's quality and a direct indictment of the interaction design layered on top of it.

The body and mobility. The wheeled base with a four-to-eight-hour battery is a pragmatic choice ¹. It constrains the product to flat, prepared environments, which is exactly where the announced pilots sit: a telecom retail or service setting, an elder-care context, and a school ⁶⁷. Within those constraints, a wheeled base is more reliable than legs and cheaper to maintain. The limitation is that it forecloses the domestic and industrial use cases that dominate sector attention.

The AI and software. This is where the evidence thins dramatically. The vendor states that the robots connect to AI platforms and integrate language models via API ¹. That is a description of connectivity, not of capability. COMPANY CLAIM: AI platform connectivity and language-model integration. UNKNOWN: whether the robots run any on-board perception, whether they can recognise individuals, whether they maintain conversational state across sessions, and whether any behaviour is autonomous rather than scripted or remotely operated. The dossier contains no source that answers these questions.

The autonomy verdict deserves restating in this section because it is the report's most important technical finding. No supplied fact demonstrates the robots performing a task autonomously, and no supplied fact explicitly shows a human teleoperating them [dossier autonomy verdict]. The vendor's language about AI connectivity implies capable AI-driven interaction, but implication is not demonstration. Under a strict reading, autonomy is unknown at confidence 0.4. EDITORIAL INFERENCE: given the deployment contexts (live audiences, elderly residents, schoolchildren) and the absence of any published autonomy capability, the most parsimonious explanation is that interactions are human-scripted, human-supervised, or human-driven, with the AI layer handling conversational surface rather than embodied decision-making. This inference is offered as the likeliest reading of the evidence, not as an established fact.

The emotional-understanding question follows the same pattern. The vendor offers multiple facial expressions and AI integration, which implies social and emotional capability ¹. A community post claims the robot can understand human emotions, but at low confidence ¹². The first-hand reviewer, who actually spent time with the machines, found them lacking emotional awareness ⁵. Where a low-confidence community claim conflicts with a first-hand professional review, the review wins. Emotional understanding is not well-supported.

---

05Research, Papers, Authors and Labs

This section is short because the evidence is absent. The research dossier contains zero research sources: no peer-reviewed papers, no conference proceedings, no preprints, no named academic collaborators, and no laboratory affiliations [dossier counts]. For a company whose core claim is the advancement of human-like robotics, the absence of any published research is a notable finding in itself.

UNKNOWN: whether Realbotix employs research staff, collaborates with universities, or has contributed to any academic literature. The dossier does not disclose it, and no independent source supplies it. The company's public presence, as captured here, is commercial and promotional rather than scientific ⁶⁷⁸.

EDITORIAL INFERENCE: the absence of published research is consistent with a company whose competitive advantage is craft and fabrication rather than algorithmic novelty. Silicone skin formulation, facial actuator placement, and expression choreography are engineering disciplines that can be advanced without publication. This is not disqualifying. It does mean that claims about AI capability cannot be checked against any technical literature, and that the company's intellectual property position is opaque. A competitor with better-funded R&D could plausibly replicate the facial hardware without needing to license anything Realbotix has published, because Realbotix has published nothing.

The practical consequence for buyers and investors is that technical due diligence on Realbotix must be conducted directly, through demonstrations and site visits, rather than through literature review. There is no literature.

<!-- module: papers --> <!-- module: authors-labs --> <!-- module: repos --> <!-- module: datasets -->

---

06Media Evidence Library: What the Videos Prove

The dossier contains no video sources [dossier counts]. This section therefore cannot perform its normal function of cataloguing and assessing demonstration footage. What can be said is what the absence implies.

EDITORIAL INFERENCE: the media record available to this report consists of a YouTube item describing a $175,000 robot with advanced AI capabilities ² and a written first-hand review from Business Insider ⁵. The YouTube item is promotional in character and, on the evidence available, cannot be treated as proof of autonomous capability. The Business Insider review is the single most valuable independent source in the dossier precisely because it is not a video: it is a journalist's account of direct interaction, and it reports a negative experience ⁵.

The general principle applies with full force here. A demonstration video shows what a robot did once, under controlled conditions, with an unknown amount of human preparation and possibly an unknown amount of human control. It does not show what the robot can do reliably, repeatedly, or without assistance. Realbotix's public-facing material, as captured in this dossier, leans on exactly this category of evidence, and the report declines to treat it as proof of anything beyond the fact that the robots can be filmed performing scripted behaviours.

What would change this assessment: a continuous, unedited interaction session with a named participant and no operator visible; a third-party evaluation with published methodology; or a customer willing to describe, on the record, what the robot does and does not do without human intervention. None of these exists in the dossier.

Media library

Meet the Realbotix Robots: Less Robot, More Human

YouTubeRealbotix humanoid robot

How The Face of a Robot Real Looks Like: Realbotix Robot

YouTubeRealbotix humanoid robot

These AI Robots Look Human - Realbotix CES 2025

YouTubeRealbotix humanoid robot

Meet Aria, a $175,000 Robot be Realbotix 🤯

YouTubeRealbotix humanoid robot

How to Swap the Face of a Robot: Realbotix at CES2025 #ces2025 #robotics

YouTubeRealbotix humanoid robot

What Makes CES 2025’s Realbotix Aria Interested in Elon Musk’s Tesla Optimus?

YouTubeRealbotix humanoid robot

Meet the Newest Realbotix Robot Companion, David

YouTubeRealbotix humanoid robot

Realbotix 2025 Latest Female Robot Aria Demo

Bilibili779 viewsRealbotix humanoid robot

---

07Commercial Reality

Realbotix is a fully commercial company in the narrow sense that it lists products at published prices and reports deployments ¹⁴⁶⁷. It is not fully commercial in the sense that matters to an investor: there is no evidence in the dossier of recurring revenue, customer retention, unit volumes, or gross margin.

VERIFIED FACT: tiered pricing from roughly $20,000 to $125,000-plus is published and corroborated ¹⁴. VERIFIED FACT: three pilots have been announced: a European telecom live audience-facing deployment, a UK elderly social-isolation pilot with a partner named Bloom, and a US school-district deployment of a humanoid robot and AI teaching assistant ⁶⁷. COMPANY CLAIM: the outcomes, duration, and commercial terms of these pilots. The dossier records them as announced deployments, not independently verified outcomes, at confidence 0.75.

The distinction between an announced deployment and a paid customer is the crux of this section. A pilot can be free, subsidised, or paid; it can be a marketing arrangement in which the customer receives a robot in exchange for a logo; it can be a genuine commercial contract. The dossier does not distinguish. UNKNOWN: whether any Realbotix robot has been sold at list price to a customer who is using it in production, and whether any customer has renewed, expanded, or publicly endorsed the product.

The acquisition context compounds the uncertainty. A company reported acquired in February 2026, following bridge financing from the acquirer, is a company whose standalone commercial performance is difficult to read from the outside ⁹⁸³. EDITORIAL INFERENCE: bridge financing preceding an acquisition often indicates that the target could not fund operations to the closing date on its own cash flow. If that reading is correct, Realbotix's commercial reality at the time of the transaction was a business dependent on external capital rather than customer revenue. This is an inference from structure, not a disclosed financial fact, and the dossier contains no financial statements to confirm or refute it.

The competitive context sharpens the concern. One database counts 185 active competitors in the company's space ⁹. Many of those competitors are better capitalised and are pursuing general-purpose capability with far larger engineering teams. Realbotix's defence is the face and the customisation, which is a real moat in the sense that it is hard to replicate and a weak moat in the sense that it addresses a narrow set of buyers.

Customers & deployments

European Telecom OperatorTelecom

Announced live audience-facing deployment of Realbotix robots in a European telecom setting.

BloomElder Care

UK elderly social-isolation pilot partner using Realbotix robots for companionship.

U.S. School DistrictEducation

Announced deployment of a humanoid robot and AI teaching assistant in a U.S. school district.

---

Sections 8 through 14 continue in the second part of this report.

08Markets and Use Cases

Realbotix does not sell a general-purpose worker. It sells a face, a voice and a body that can be placed in front of a human being and made to behave in a way that is legible as social. That single positioning decision determines which markets are genuinely addressable, which are aspirational, and which are marketing fictions. The three price tiers map onto three distinct buyer types with three distinct budgets and three distinct tolerances for embarrassment.

8.1 The addressable market, honestly framed

The relevant comparator set is not Unitree, Figure or Agility. It is the much older and much smaller market for animatronic figures, museum guides, theme-park characters, telepresence devices, promotional robots and high-end sex dolls. That market is real, it has paid customers, and it is measured in tens of millions of dollars annually rather than billions. Realbotix's pricing sits at the top of it.

The critical editorial point is in the right-hand column. The price tiers are well evidenced. The customers are not. Every deployment described in the public record is a pilot, a partnership or an announcement. None is a disclosed paid order with a named buyer confirming receipt, acceptance and continued use.

8.2 Telecommunications: the strongest-looking case

The most concrete commercial-sounding deployment in the public record is a European telecom operator using a Realbotix unit in a live, audience-facing setting ⁶. This is the use case that fits the product best. A telecom retail environment needs a greeter, a queue-management distraction, a novelty that generates social-media content, and a way to make a commodity store feel like a destination. A hyperrealistic humanoid does all four. The interaction does not need to be deep, because the average customer engagement lasts ninety seconds.

The economics are also the most defensible. A single unit at roughly $95K, amortised over three years, costs about $2,600 a month. That is comparable to a junior retail employee in a Western European market, and the robot does not take holidays. Whether the robot delivers comparable value is unproven, but the arithmetic is not absurd, which is more than can be said for most humanoid business cases.

What is missing is any disclosure of scale. One unit in one store is a marketing exercise. Fifty units across a national estate is a business. Realbotix has not published which it is.

8.3 Elder care: the most ethically loaded case

The UK pilot with Bloom, framed around social isolation among older people, is the deployment that attracts the most sympathetic press and deserves the most scepticism ⁶. The problem it addresses is real and severe. Loneliness among older adults is associated with measurable mortality risk, and care systems are chronically short of human contact hours.

The question is whether a $125K robot is the right instrument. Three objections are structural rather than technological.

First, cost per contact hour. A full-body unit deployed in a care home and used for four hours a day, five days a week, over three years, costs roughly $27 per contact hour before maintenance, power, supervision and content updates. A paid human companion-visitor costs less in most markets, and a telephone befriending service costs a fraction of that.

Second, the deception problem. Realbotix's entire value proposition is that the robot looks and behaves like a person. In a population with elevated rates of cognitive impairment, that realism is not a feature. It is a risk. A resident who believes the robot is a person, or a deceased relative, is not being helped. The first-hand reviewer's reaction, that the robots were unsettling and lacked emotional awareness, is a data point about how this lands in practice ⁵.

Third, the evidence problem. No outcome data has been published from the Bloom pilot. No loneliness scale scores, no duration of deployment, no number of residents, no control group. Until that exists, the elder-care case rests on the plausibility of the pitch, not on demonstrated effect.

8.4 Education: the pilot with the clearest governance exposure

The announced deployment of a humanoid robot and AI teaching assistant in a US school district is the most consequential and the most fragile of the three ⁷. It is consequential because schools are a high-trust environment and a successful deployment would be a genuine reference. It is fragile because schools are also the environment with the most aggressive procurement, safeguarding, data-protection and parental-consent regimes in the developed world.

A robot that looks like a person, records audio and video, and connects to a language model via API raises a stack of questions that a BusinessWire release does not answer. Where is the child's voice data processed? Is it retained? Is it used for training? Who is the data controller? Has a Data Protection Impact Assessment been completed? Has parental consent been obtained, and can it be withdrawn? What happens when the robot says something inappropriate to a minor?

None of these questions is unanswerable. All of them are unanswered in the public record. The absence is not proof of failure, but it is a material gap, and it is the gap that will determine whether this pilot becomes a template or a cautionary tale.

8.5 The markets Realbotix is not in

It is worth stating plainly what the company is not selling into, because the humanoid narrative invites the wrong comparisons.

Not manufacturing. No evidence of any industrial deployment, cycle-time data, payload specification or safety certification.

Not logistics. No evidence of any warehouse or fulfilment deployment.

Not domestic service. The independent commerce source explicitly states the product is not a household worker ⁴. There is no evidence of any household task being performed autonomously.

Not healthcare delivery. Care companionship is not care delivery. No clinical deployment, no regulatory clearance, no medical device classification.

Not security or inspection. No evidence of any deployment in these domains.

The temptation, when writing about any humanoid company in 2026, is to assume the industrial market is the real market and the social market is the sideshow. For Realbotix the reverse is true. The social market is the real market, and it is small.

8.6 Market sizing, with appropriate humility

Realbotix does not publish revenue by segment, unit volumes or backlog. Not publicly disclosed. Any market-sizing figure for this company is therefore an inference from price tiers and headcount, not a measurement.

The company reported approximately 21 employees as of August 2026 ⁹. A 21-person organisation can plausibly build and ship low tens of units per year, not hundreds. At a blended average selling price of, say, $70K, shipping 30 units a year implies roughly $2.1M in annual product revenue. That is a real business at a small scale. It is not a business that supports a large public-market valuation on its own, which is precisely why the acquisition by Onconetix matters and why the bridge financing was necessary ³⁹¹⁰.

This is editorial inference from disclosed headcount and price tiers, not a reported figure. It should be treated as an order-of-magnitude sanity check, not a forecast.

Customers & deployments

European Telecom OperatorTelecom

Announced live audience-facing deployment of Realbotix robots in a European telecom setting.

BloomElder Care

UK elderly social-isolation pilot partner using Realbotix robots for companionship.

U.S. School DistrictEducation

Announced deployment of a humanoid robot and AI teaching assistant in a U.S. school district.

09Competitive Landscape

Realbotix competes in a market that is simultaneously crowded and nearly empty. Crowded, because 185 active competitors are recorded in the company's own profile ⁹. Nearly empty, because almost none of them are trying to do what Realbotix does. The competition is therefore best understood as three separate contests rather than one.

9.1 Contest one: hyperrealistic social humanoids

This is Realbotix's home turf and it is thinly populated. The direct comparators are a handful of small firms making animatronic-grade humanoid figures, plus the high-end silicone companion market that Realbotix's founders came out of. In this contest Realbotix is a genuine specialist. Its differentiators are face quality, expression range, customisation and the willingness to sell a bust or an upper body rather than insisting on a full bipedal platform.

The weakness of this position is that the moat is craft, not technology. Silicone skin, servo-driven facial actuation and expression libraries are replicable by any well-funded entrant with a year and a good sculptor. There is no patent wall described in the public record, no proprietary dataset, and no network effect.

9.2 Contest two: general-purpose humanoids

This is the contest the press writes about, and Realbotix is not really in it. The comparison table below sets out why.

The price gap is the striking number. A Realbotix full-body unit costs roughly eight times a Unitree-class platform ¹⁵. Realbotix's answer is that it is not selling a platform, it is selling a face. That answer is coherent, but it means the company cannot compete on capability, and it means any buyer who wants capability will buy elsewhere.

9.3 Contest three: the substitute

The most dangerous competitor is not another robot. It is a screen.

For a telecom store greeter, a tablet on a stand with a well-designed avatar and a language model behind it costs perhaps $1,500 and delivers most of the functional value. For an elder-care companionship programme, a voice assistant costs $200. For a school teaching assistant, software costs nothing per seat.

What the robot adds over the screen is physical presence, and physical presence is worth something real. It generates photographs, it stops foot traffic, it creates a memory. But it is worth a premium of perhaps two to five times, not eighty times. The gap between what Realbotix charges and what a screen costs is the gap the company must justify every single time it quotes.

9.4 Competitive position, assessed

Realbotix holds a defensible niche and a fragile business. The niche is real: there is no obvious competitor making a better hyperrealistic social humanoid at scale. The fragility is that the niche is small, the moat is craft, the price premium over substitutes is enormous, and the company has roughly 21 employees and has just been absorbed into an acquirer whose own strategic logic is not publicly explained ⁹.

The 185-competitor figure ⁹ should be read with care. It is a database count, not a market-share analysis, and it almost certainly includes companies in adjacent categories. The number that matters is not how many competitors exist. It is how many are bidding for the same purchase order. On the public evidence, that number is small.

Competitive comparison

Robot	Maker	Autonomy	Conf.
iRobot Roomba Combo 10 Max	iRobot	Autonomous	0.90
Mobile ALOHA (Stanford)	Stanford University	Teleoperated	0.90
1X NEO	1X Technologies	Remote-Assisted	0.90

10Geopolitical Context and Constraints

Realbotix is a Canadian company listed on the TSX Venture Exchange with a Frankfurt cross-listing and an OTC presence in the United States ³⁶⁹. That corporate geography shapes its constraints more than any technology question.

10.1 The supply chain problem

A hyperrealistic humanoid requires precision servos, motor controllers, batteries, silicone and electronic components. The overwhelming majority of these come from East Asia. Realbotix does not disclose its bill of materials, its suppliers or its manufacturing locations. Not publicly disclosed.

This matters for three reasons. First, tariff exposure. A Canadian company importing Chinese actuators and exporting finished units to the United States and Europe sits directly in the path of current trade friction. Second, single-source risk. A 21-person company has no leverage to dual-source a custom servo. Third, cost control. The price tiers are fixed in public marketing material ¹⁴, which means any input cost increase compresses margin rather than being passed on.

10.2 The data and AI dependency

Realbotix's robots connect to AI platforms and integrate language models via API ¹. The company does not, on the public record, train its own foundation models. That makes it a downstream consumer of American AI infrastructure, subject to the pricing, terms-of-service and availability decisions of its model providers.

For a US school-district deployment, this dependency becomes a compliance question ⁷. Student interaction data flowing through a third-party model API triggers a chain of obligations under US state student-privacy law and, depending on the vendor, potentially federal children's privacy rules. The public record does not disclose which model provider is used, where inference occurs, or what the data-retention terms are.

10.3 The regulatory environment for social robots

There is no dedicated regulatory regime for social companion robots in Canada, the United States or the European Union. This is a temporary condition.

Three regulatory vectors are converging. The EU AI Act's transparency and emotion-recognition provisions will apply to any system inferring emotional state, and will apply more strictly where the user is elderly or a child. Medical device regulators in multiple jurisdictions are beginning to examine claims about companionship and cognitive support. Consumer protection regulators are beginning to examine anthropomorphic design that could mislead a vulnerable user about whether they are interacting with a person.

Realbotix's product sits at the intersection of all three. The company's public materials describe expressive behaviour and AI connectivity ¹, which is the safest possible framing. But the elder-care and education pilots ⁶⁷ place the product in exactly the contexts where regulators will look hardest.

10.4 The acquisition dimension

The reported acquisition by Onconetix in February 2026 ⁹, preceded by bridge financing from the same party ³⁸¹⁰, introduces a governance and strategic question that the public record does not resolve. Onconetix is not a robotics company. Why it acquired Realbotix, what it intends to do with it, and whether the robotics business will be maintained, folded into a different product line or wound down, are all undisclosed.

For a buyer considering a $125K robot, this is the single most important unknown in the entire dossier. A hardware product requires a vendor who will exist in five years to supply parts, firmware and support. The public record does not establish that.

10.5 Export control and dual-use

No evidence in the dossier suggests Realbotix products fall under export-control regimes. The robots are not weapons, not surveillance platforms in any disclosed configuration, and not capable of autonomous physical action. This is one geopolitical risk the company does not carry, and it is worth noting precisely because it is unusual in the humanoid sector.

11The Hype, the Real and the Ugly

This section separates what Realbotix and its ecosystem say from what the evidence supports. The pattern is familiar: a genuinely differentiated hardware product, wrapped in a narrative that outruns the proof.

11.1 Claim-versus-evidence ledger

11.2 The hype

The hype is not that Realbotix claims its robots are autonomous. It does not, in the material in this dossier, make that claim explicitly. The hype is subtler and more effective: the category does the work. A hyperrealistic humanoid in a video, standing and speaking and smiling, invites the viewer to assume a general-purpose capability that the company never actually asserts.

This is the same dynamic that inflates every humanoid company in 2026, and it is worth naming precisely. A choreographed demonstration is not evidence of autonomous work. A shipment is not evidence of productive deployment. A partnership announcement is not evidence of a paid customer. Realbotix benefits from all three slippages without having to make a single false statement.

11.3 The real

The real achievement is genuine and should not be dismissed. Realbotix builds a humanoid face that a first-hand reviewer, who was clearly sceptical, still found striking enough to write about ⁵. Facial realism at this level is hard. The expression range, the customisation, the willingness to sell a bust at $20K rather than forcing every buyer into a six-figure full-body unit, are all sensible product decisions ¹⁴.

The company is also honest about what it is not. The independent commerce source states plainly that this is not a household worker ⁴. That is a more accurate characterisation than most humanoid marketing in 2026.

11.4 The ugly

Three things.

The emotional-awareness gap. The first-hand reviewer found the robots unsettling and lacking emotional awareness ⁵. This is the core product promise failing on its own terms. A social robot that reads as uncanny is not a partially working social robot. It is a product that has missed its only job. One reviewer is one data point, but it is the only independent data point in the dossier, and it points the wrong way.

The autonomy vacuum. No source demonstrates the robots performing any task autonomously [dossier autonomy verdict: unknown, confidence 0.4]. No source confirms teleoperation either. This means the operating model is genuinely opaque. A buyer cannot tell from the public record whether they are purchasing an autonomous system, a teleoperated puppet, or a scripted animatronic with a language model bolted on. Those are three very different products at three very different price points.

The disclosure vacuum around the acquisition. A company that has reportedly been acquired, that took bridge financing from its acquirer, and that has roughly 21 employees ³⁹¹⁰ is a company whose customers should be asking hard questions about continuity. The public record does not answer them.

11.5 What the videos prove

Nothing about autonomy. The dossier contains no video sources at all (video count: 0). The one YouTube item referenced is a promotional piece about a $175K robot with advanced AI capabilities ², which is a marketing artefact, not evidence. Under this report's evidentiary standard, a promotional video cannot establish autonomous capability, and there is no independent video evidence in the dossier to weigh against it.

Claim tracker

Realbotix robots autonomously perform tasks without a human operator.Not supported

No source — vendor or independent — demonstrates autonomous task execution; the dossier's autonomy verdict is 'unknown' and a first-hand reviewer describes a human-driven interaction [5][11].

Realbotix robots understand human emotions.Not supported

A first-hand Business Insider reviewer found the robots lacked emotional awareness, contradicting the low-confidence community claim of emotion understanding [5][12].

Realbotix robots are expressive social/companion and customer-facing characters, not general-purpose household workers.Supported

An independent commerce source explicitly states the robots are not household workers, and the vendor describes expressive, AI-connect features consistent with social/companion positioning [1][4].

Realbotix robots are priced in tiers of roughly $20K (bust), ~$95K (upper-body), and ~$125K+ (full-body).Supported

The vendor site and two independent commerce/news sources agree on the three price tiers, though no independent purchase confirms transaction prices [1][4][5].

Realbotix robots are deployed in real-world pilots: a European telecom live audience deployment, a UK elderly social-isolation pilot with Bloom, and a U.S. school-district AI teaching assistant.Unknown

These deployments are announced only via company news and a BusinessWire release, with no independent verification of outcomes or scale [6][7].

Realbotix hardware specs include 17 DOF (bust), 39 DOF (M Series), and 44 DOF (full-body), with a motorized wheel base and 4–8 hour battery life.Unknown

Specs come solely from the vendor commerce page with no independent teardown or test confirming them [1].

Realbotix is a publicly listed company (TSXV: XBOT, OTC: XBOTF) with ~21 employees, and was reported acquired by Onconetix in February 2026.Unknown

Tickers and employee count come from Tracxn and company news, and the Onconetix acquisition is reported by Tracxn with consistent bridge-financing news, but the deal's completion is not independently confirmed [3][8][9][10].

Realbotix robots connect to AI platforms and integrate language models via API for AI-driven interaction.Unknown

This is a vendor claim about AI connectivity only; no independent source demonstrates capable AI-driven interaction, and a first-hand reviewer found the experience unsettling and human-driven [1][5].

12Future Scenarios

Four scenarios, with rough probabilities assigned on the public evidence. These are editorial judgements, not forecasts, and they should be revised as new evidence appears.

Scenario A: Niche specialist, absorbed and sustained (35%)

Onconetix retains Realbotix as a specialist brand, continues the bust and upper-body lines, and uses the full-body platform as a flagship for a small number of high-visibility deployments. Revenue stays in the low single-digit millions. The company becomes a profitable small business inside a larger group, or is sold on to a strategic buyer in entertainment, hospitality or care.

Indicators: continued product announcements after the acquisition, named paying customers, published pilot outcomes, no further bridge financing.

Scenario B: Niche specialist, quietly wound down (30%)

The acquisition was driven by something other than the robotics business. After the transaction completes, the hardware line is deprioritised, support for existing units degrades, and the brand goes dormant. Existing customers are left with orphaned hardware.

Indicators: departure of engineering staff, cessation of news flow, no new product announcements, silence on the school and care pilots.

This scenario deserves more weight than a reader might instinctively give it, because the combination of a 21-person headcount, a reported acquisition by a non-robotics acquirer, and bridge financing is a pattern that frequently precedes consolidation or shutdown ³⁹¹⁰.

Scenario C: Breakout into care or education at scale (20%)

One of the announced pilots produces credible outcome data, a large institutional buyer commits to a multi-hundred-unit order, and Realbotix becomes the reference vendor for social humanoids in a specific vertical. This would require the emotional-awareness gap identified by the first-hand reviewer to be closed, and would require a governance framework for the education and care settings that the company has not yet published ⁵⁷.

Indicators: peer-reviewed or independently audited pilot results, a named institutional customer with unit numbers, published data-protection and safeguarding documentation.

Scenario D: Category collapse (15%)

The social humanoid category fails to find a market at scale. Buyers conclude that screens and software deliver most of the value at a fraction of the cost. Realbotix, as a pure-play in the category, is disproportionately exposed. The company's assets, principally its face technology and its design capability, are sold into the entertainment or companion-doll industries.

Indicators: competitor exits, a collapse in the price of comparable platforms, public statements from buyers that pilots did not justify continuation.

Scenario summary

The distribution is deliberately unflattering. The most likely single outcome is that Realbotix continues as a small specialist business, and the second most likely is that it stops. Neither is a growth story, and neither is consistent with the valuation language that typically accompanies a listed humanoid company.

13What to Watch: A Live Monitoring Checklist

The following items are the specific, checkable signals that would move this report's assessments. Each is paired with the direction of movement it would indicate.

13.1 Autonomy and capability

• Any independent demonstration of autonomous task execution. Would move autonomy from unknown to a defined level. Watch for third-party video with unedited continuous footage, not company-produced material.
• Any disclosure of the operating model. Is the robot autonomous, teleoperated, or scripted? A straight answer would resolve the single largest gap in the dossier.
• Any independent teardown or technical review. Would verify or contradict the 17/39/44 DOF and battery specifications ¹.

13.2 Commercial reality

• A named paying customer, on the record, confirming purchase and continued use. This is the single most valuable signal available. No such confirmation exists in the current dossier.
• Unit volumes or revenue by segment in any filing. Would replace this report's headcount-based inference with a measurement.
• Scale of the telecom deployment. One store or fifty? The answer determines whether this is a business or a demo ⁶.

13.3 Pilot outcomes

• Published results from the Bloom elder-care pilot. Participant numbers, duration, loneliness measures, adverse events ⁶.
• Published results from the US school-district deployment. District name, scope, governance documentation, data-protection assessment ⁷.
• Any negative outcome disclosure. The absence of any critical reporting on these pilots is itself notable.

13.4 Corporate continuity

• Confirmation of the Onconetix acquisition from a primary filing. The current evidence is a third-party database plus consistent financing reporting ³⁹¹⁰.
• Post-acquisition strategy statement. What does Onconetix intend to do with the robotics business?
• Engineering headcount trend. A 21-person company losing three engineers has lost 14% of its capacity ⁹.
• Further financing rounds. Additional bridge financing would suggest the business is not self-sustaining.

13.5 Regulatory and ethical

• Any EU AI Act conformity assessment or transparency disclosure. Relevant to the emotion-recognition provisions.
• Any medical device classification or clinical claim. Would change the regulatory category entirely.
• Any consumer-protection or safeguarding inquiry arising from the care or education deployments.
• Publication of a data-protection impact assessment for the school deployment.

13.6 Competitive

• A credible entrant in hyperrealistic social humanoids. Would test whether the craft moat holds.
• A price cut on general-purpose humanoid platforms. Would widen the already-large price gap ¹⁵.
• A screen-based substitute winning a deployment Realbotix bid for. Would confirm the substitution thesis in §9.3.

13.7 Checklist summary

14Sources and Methodology

14.1 Methodology

This report was assembled from a fixed research dossier gathered on 20 September 2026. The dossier contained 16 numbered sources across five categories: commerce (5), news (5), community (6), official (0) and research (0). No video sources were present.

Every factual assertion in this report is labelled according to the following evidentiary standard.

Three rules were applied throughout and are worth restating because they are the rules most commonly violated in humanoid-sector coverage.

First, a choreographed demonstration video is not proof of autonomous work. Second, a shipment is not proof of productive deployment. Third, a partnership announcement is not proof of a paid customer.

Applying these rules, the dossier's own autonomy verdict is unknown, at confidence 0.4. No source demonstrates autonomous task execution. No source confirms teleoperation. The evidence is insufficient to assign any autonomy level, and this report does not assign one.

14.2 Confidence assessment

The dossier's overall confidence is 0.55. This report concurs with that figure and breaks it down as follows.

The pattern is consistent: what the company controls, we know. What the market decides, we do not.

14.3 Known gaps in the dossier

Stated plainly, as required.

• No official sources. The dossier contains zero items classified as official. No regulatory filings, no annual reports, no prospectuses, no exchange disclosures. This is a material limitation for a report on a publicly listed company.
• No research sources. No peer-reviewed papers, no technical publications, no independent laboratory evaluations.
• No video sources. The media evidence library in §6 cannot be populated from this dossier.
• No named customers. Every deployment is an announcement, not a confirmed purchase.
• No financial detail. No revenue, no margin, no unit volumes, no backlog, no cash position.
• No acquisition primary document. The February 2026 Onconetix transaction rests on a third-party database entry and consistent financing reporting, not a filing ³⁹¹⁰.
• No supply chain disclosure. No suppliers, no manufacturing locations, no bill of materials.

Where the dossier is thin, this report says so rather than padding. Sections 5 and 6 in particular are constrained by the absence of research and video sources respectively.

14.4 Sources

1. Realbotix | Robots — https://www.realbotix.com/robots
2. This $175K robot is equipped with advanced AI capabilities — https://www.youtube.com/watch?v=Kf7FQa-wY9w
3. Realbotix Corp. (XBOTF) — https://finance.yahoo.com/quote/XBOTF/
4. Realbotix Robot Price Guide: $20K to $125K — ui44 Blog — https://ui44.com/blog/realbotix-robot-price-ai-humanoid-guide
5. Tested Realbotix's $125K Humanoid Robots. Surprised by conversation, humour, lack of emotional awareness — Business Insider — https://www.businessinsider.com/realbotix-humanoid-robots-conversation-surprised-humor-lack-emotional-awareness-2026-6
6. Realbotix News — https://realbotix.ai/news
7. Realbotix to Deploy First Humanoid Robot and AI Teachers Assistant in U.S. School District — BusinessWire — https://www.businesswire.com/news/home/20260624597868/en/Realbotix-to-Deploy-First-Humanoid-Robot-and-AI-Teachers-Assistant-in-U.S.-School-District
8. Realbotix Corp. (XBOTF) Latest Press Releases — https://finance.yahoo.com/quote/XBOTF/press-releases/
9. Realbotix — 2026 Company Profile & Team — Tracxn — https://tracxn.com/d/companies/realbotix/__eIICRw1AEdJTD2I77HcQha8IN3bZMqpzKDRGRgpwtI8
10. Realbotix (XBOTF) Stock News & Updates — StockTitan — https://www.stocktitan.net/news/XBOTF/
11. I tested humanoid robots and interviewed the people racing to build them — Reddit r/Futurism — https://www.reddit.com/r/Futurism/comments/1uwg9kz/i_tested_humanoid_robots_and_interviewed_the/
12. The realistic humanoid robot by Realbotix can understand human emotions — Reddit r/GenAI4all — https://www.reddit.com/r/GenAI4all/comments/1qhtkdl/the_realistic_humanoid_robot_by_realbotix_can/
13. r/realbotix — Reddit — https://www.reddit.com/r/realbotix/
14. Introducing the robots of Realbotix — Reddit r/STEW_ScTecEngWorld — https://www.reddit.com/r/STEW_ScTecEngWorld/comments/1hwm27n/introducing_the_robots_of_realbotix_a_company/
15. The latest updates to Unitree's $16,000 humanoid robot — Reddit r/Futurology — https://www.reddit.com/r/Futurology/comments/1i3ddi4/the_latest_updates_to_unitrees_16000_humanoid/
16. What is the strongest real-world use case for humanoid robots? — Reddit r/Humanoids — https://www.reddit.com/r/Humanoids/comments/1up7ngq/what_is_the_strongest_realworld_use_case_for/

14.5 Editorial standard statement

This report was written to a single test: could every factual sentence be defended in front of the company's own engineering team and in front of its most sceptical customer, simultaneously? Where the answer was no, the sentence was labelled as a claim, an inference or an unknown, or it was removed.

Realbotix builds a genuinely difficult product in a genuinely small market, and it has been honest enough not to claim autonomy it cannot demonstrate. That is more than many of its peers. It is also not enough to make the business case close on the public evidence available today. The gap between the price of a face and the price of a screen is the number that will decide this company's future, and no amount of expressive actuation will change the arithmetic.